Search
Close this search box.

Pipeline

While IGD-AD1 is the furthest in the clinical trials pipeline, IGC Pharma is actively building a portfolio of both plant-derived and manufactured molecules that can address multiple areas of unmet medical needs.

While IGD-AD1 is the furthest in the Clinical Trials pipeline, IGC Pharma is actively building a portfolio of both Plant-derived and manufactured molecules that can address multiple areas of unmet medical needs.